Maehara, Yoshihiko
Oki, Eiji
Ota, Mitsuhiko
Harimoto, Norifumi
Ando, Koji
Nakanishi, Ryota
Kawazoe, Tetsuro
Fujimoto, Yoshiaki
Nonaka, Kentaro
Kitao, Hiroyuki
Iimori, Makoto
Makino, Kunio
Takechi, Teiji
Sagara, Takeshi
Miyadera, Kazutaka
Matsuoka, Kazuaki
Tsukihara, Hiroshi
Kataoka, Yuki
Wakasa, Takeshi
Ochiiwa, Hiroaki
Kamahori, Yoshihiro
Tokunaga, Eriko
Saeki, Hiroshi
Yoshizumi, Tomoharu
Kakeji, Yoshihiro
Shirabe, Ken
Baba, Hideo
Shimada, Mitsuo
Article History
Received: 28 February 2023
Accepted: 1 March 2023
First Online: 24 March 2023
Declarations
:
: Yoshihiko Maehara, Mitsuhiko Ota, Norifumi Harimoto, Koji Ando, Ryota Nakanishi, Tetsuro Kawazoe, Yoshiaki Fujimoto, Kentaro Nonaka and Tomoharu Yoshizumi have no conflicts of interest. Eiji Oki received honoraria from Taiho Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., and Daiichi-Sankyo Pharmaceutical Co. Ltd.. Hiroyuki Kitao received research funding from Taiho Pharmaceutical Co. Ltd.. Makoto Iimori received research funding from Taiho Pharmaceutical Co. Ltd.. Eriko Tokunaga received honoraria from Daiichi-Sankyo Pharmaceutical Co. Ltd.. Hiroshi Saeki received honoraria and scholarship donation from Taiho Pharmaceutical Co. Ltd.. Yoshihiro Kakeji received honoraria and scholarship donation from Taiho Pharmaceutical Co. Ltd.. Ken Shirabe received a scholarship donation from Taiho Pharmaceutical Co. Ltd.. Hideo Baba received honoraria from Taiho Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., and Daiichi-Sankyo Pharmaceutical Co. Ltd., research funding from Taiho Pharmaceutical Co. Ltd., and Ono Pharmaceutical Co. Ltd., and scholarship donation from Taiho Pharmaceutical Co. Ltd.. Mitsuo Shimada received research funding from Taiho Pharmaceutical Co. Ltd.. Kunio Makino、Teiji Takechi、Takeshi Sagara、Kazutaka Miyadera、Kazuaki Matsuoka、Hiroshi Tsukihara、Yuki Kataoka、Takeshi Wakasa、Hiroaki Ochiiwa、and Yoshihiro Kamahori are employees of Taiho Pharmaceutical Co. Ltd. Dr. Yoshihiko Maehara has no conflicts of interest with Dr. Ken Shirabe and Japan Society of Clinical Oncology